Integrating Multi-Omics Reveals Crucial Biomarkers in Non-Alcoholic Fatty Liver Disease

Yuping Zeng,Xia Wang,He,Lidan Yang,Shuangqin Li,Zhenmei An
DOI: https://doi.org/10.2139/ssrn.3915431
2021-01-01
Abstract:Background: Non-alcoholic fatty liver disease (NAFLD) has now become the leading cause of liver-related morbidity and mortality. However, the related pathogenesis remains unclear. This study intended to screen crucial biomarkers and reveal relevant mechanism of NAFLD by integrating multi-omics.Methods: C57BL/6J mice were fed with normal, high-fat, and methionine choline-deficient diets to establish Control, simple steatosis (SS), and non-alcoholic steatohepatitis (NASH) groups. We measured transcriptomics, proteomics, and acetylated proteomics on mouse liver tissues. Bioinformatics and association analysis of multi-omics were performed by R (v 4.0.3). We established NAFLD cell models to validate the expression levels of crucial proteins (genes) by targeted proteomics and real-time quantitative PCR.Results: HE staining suggested successful modeling of NAFLD mice models. 129 genes, 62 proteins, and 38 acetylated proteins were differentially expressed in NASH vs. Control and SS vs. Control groups. These genes (proteins) were mainly involved in pyruvate metabolism, carbon metabolism, and the AMPK-PPAR signaling pathway. By association analysis, we found the expression levels of Cyp2e1, Hmgcs2, and Pfkm were inconsistent among omics. Furtherly by verification, we found Pck1, Acacb, Cd36, and Scd1 were significantly differentially expressed in NAFLD cell models compared with negative control.Conclusion: Pck1, Acacb, Cd36, and Scd1 were crucial biomarkers and potential therapeutic targets for NAFLD. Genes with inconsistent expression such as Cyp2e1, Hmgcs2, and Pfkm might be regulated by post-translational modifications of acetylation. The relevant mechanisms needed to be studied furtherly.Funding Statement: This study was funded by the Sichuan Science and Technology Department (2018SZ0382) and the National Natural Science Foundation of China (81902142).Declaration of Interests: No conflicts of interest.Ethics Approval Statement: This study was approved by the Ethics Committee of the Animal Center of Sichuan University (2021257A).
What problem does this paper attempt to address?